Novel Immunotherapy Combos Show Promise in Stage III Non-Small Cell Lung Cancer
Combining either oleclumab or monalizumab with durvalumab provided a progression-free survival benefit over durvalumab alone.
All articles by Sucharita Mistry, PhD
Vitamin D, Omega-3s, and Exercise May Reduce Cancer Risk in Older Adults
Researchers observed a 61% reduction in the risk of invasive cancer among patients who completed a home exercise program and took vitamin D3 and omega-3 fatty acids daily.
Biomarkers May Help Guide Treatment in Cancer Patients With COVID-19
Three biomarkers were associated with prognosis after COVID-19 treatment.
PHS290 May Help Predict Lifetime Risk of Metastatic or Fatal Prostate Cancer
Men of African ancestry had the highest risk of developing metastatic prostate cancer when compared with men of other ancestries.
AI Platform Identifies Thyroid Cancer ‘With High Accuracy’
The multimodal AI platform proved more accurate than deep learning alone.
Increased Risk of Neurocognitive Difficulties in Survivors of Bone Cancer
Researchers sought to measure the risk of long-term neurocognitive outcomes in survivors of osteosarcoma and Ewing sarcoma.
3MT Gene Signature May Predict Poor Outcomes in Neuroblastoma
Elevated urinary 3MT levels were tied to worse event-free and overall survival.
Neoadjuvant Chemoradiotherapy Improves Long-Term OS in Pancreatic Cancer
In addition to improved overall survival, patients in the neoadjuvant arm had longer disease-free survival and locoregional failure-free intervals.
Antihistamines May Reduce Risk of Hepatocellular Carcinoma in Patients With Viral Hepatitis
Researchers found a dose-response relationship between antihistamine use and the risk of hepatocellular carcinoma in patients with viral hepatitis.
Opioid Use Linked to Survival in Older Patients With Advanced Pancreatic Cancer
The median survival was significantly longer in patients who received opioid prescriptions than in those who did not.
- Loading...
Loading...
Next post in Oncology
Loading... 
Loading...